<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 14.5: Senescence and Senolytics: Clearing 'Zombie Cells'</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Advanced Modules */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            padding: 15px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            border-left: 4px solid #4caf50;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f1f5f9;
            border-left: 5px solid #1e3a8a;
            padding: 25px 30px;
            margin: 40px 0;
            border-radius: 0 12px 12px 0;
        }

        .takeaways-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
            text-transform: uppercase;
            letter-spacing: 1px;
            font-size: 14px;
        }

        /* References Box */
        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            margin-top: 40px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 14: Advanced Longevity Deep Dive</p>
            <h1 class="lesson-title">Lesson 14.5: Senescence and Senolytics: Clearing 'Zombie Cells'</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level: Expert</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biology"><span class="section-num">1</span>The Biology of Senescence</a></li>
                <li><a href="#sasp"><span class="section-num">2</span>SASP and Systemic Inflammaging</a></li>
                <li><a href="#natural"><span class="section-num">3</span>Natural Senolytics: Fisetin & Quercetin</a></li>
                <li><a href="#autophagy"><span class="section-num">4</span>Autophagy vs. Senolysis</a></li>
                <li><a href="#clinical"><span class="section-num">5</span>Pharmaceutical Status: Dasatinib</a></li>
                <li><a href="#pulsing"><span class="section-num">6</span>The Pulsing Protocol & Safety</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define cellular senescence and the mechanisms of the "Zombie Cell" phenomenon.</li>
                <li>Analyze the components of the Senescence-Associated Secretory Phenotype (SASP) and its role in biological aging.</li>
                <li>Evaluate the efficacy of natural compounds like Fisetin and Quercetin based on human clinical data.</li>
                <li>Distinguish between senolytic mechanisms and autophagy-inducing pathways.</li>
                <li>Design a safe, evidence-based pulsing schedule for senolytic interventions.</li>
            </ul>
        </div>

        <h2 id="biology">1. The Biology of Senescence: Beyond the Hayflick Limit</h2>
        <p>For decades, biology focused on the <span class="highlight">Hayflick Limit</span>‚Äîthe observation that human cells can only divide a finite number of times before reaching a state of permanent arrest. We once believed these cells simply "quit." However, we now know that many of these cells do not die via apoptosis. Instead, they enter a state of <span class="highlight">cellular senescence</span>.</p>

        <p>In a youthful state, senescent cells are beneficial; they play a role in wound healing and tumor suppression. However, as we age, the immune system‚Äôs ability to clear these cells declines. By the time an individual reaches age 70, senescent cells can comprise up to <span class="stat-highlight">10-15% of the total cell population</span> in certain tissues, such as adipose tissue and the skin.</p>

        <p>These "Zombie Cells" are metabolically active but no longer divide. They resist death by upregulating <span class="highlight">Senescent Cell Anti-Apoptotic Pathways (SCAPs)</span>, effectively shielding themselves from the body's natural "cleanup" signals. As part of the <strong>A.G.E.L.E.S.S. Longevity Protocol‚Ñ¢</strong>, addressing these cells is a critical component of the "S" (Supplements & Biohacks) pillar, working in tandem with the "E" (Exercise) pillar to stimulate immune-mediated clearance.</p>

        <div class="key-terms-box">
            <p class="box-label">Key Terms</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Senolytic</p>
                    <p class="definition">A class of small molecules that selectively induce death in senescent cells by inhibiting their anti-apoptotic pathways.</p>
                </div>
                <div class="term-item">
                    <p class="term">Senomorphic</p>
                    <p class="definition">Compounds that suppress the inflammatory secretions (SASP) of senescent cells without necessarily killing the cells.</p>
                </div>
                <div class="term-item">
                    <p class="term">Apoptosis</p>
                    <p class="definition">Programmed cell death; the "clean" way cells are removed from the body when they are damaged or redundant.</p>
                </div>
            </div>
        </div>

        <h2 id="sasp">2. SASP: The Inflammatory "Soup" of Aging</h2>
        <p>The danger of senescent cells lies not in their lack of function, but in what they secrete. This is known as the <span class="highlight">Senescence-Associated Secretory Phenotype (SASP)</span>. Senescent cells pump out a toxic cocktail of pro-inflammatory cytokines, chemokines, and matrix metalloproteinases (MMPs).</p>

        <p>A single senescent cell can "infect" its neighbors through a paracrine effect‚Äîthe <span class="highlight">Bystander Effect</span>. By secreting SASP factors, a zombie cell triggers senescence in healthy adjacent cells, creating a cascade of tissue degradation. This is a primary driver of <strong>Inflammaging</strong>, the chronic, low-grade inflammation that accelerates nearly all age-related diseases.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>SASP Component</th>
                        <th>Biological Effect</th>
                        <th>Clinical Manifestation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>IL-6 & IL-1Œ≤</td>
                        <td>Systemic pro-inflammatory signaling</td>
                        <td>Insulin resistance, muscle wasting</td>
                    </tr>
                    <tr>
                        <td>MMPs (Proteases)</td>
                        <td>Breakdown of extracellular matrix</td>
                        <td>Skin wrinkles, joint degradation</td>
                    </tr>
                    <tr>
                        <td>VEGF</td>
                        <td>Pathological angiogenesis</td>
                        <td>Increased cancer risk, macular degeneration</td>
                    </tr>
                    <tr>
                        <td>IGFBP-7</td>
                        <td>Induces senescence in neighboring cells</td>
                        <td>Accelerated tissue aging (Bystander Effect)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="natural">3. Natural Senolytics: Fisetin, Quercetin, and Piperlongumine</h2>
        <p>The discovery of natural compounds with senolytic properties has revolutionized the longevity field. Unlike pharmaceutical interventions, many of these are <span class="highlight">polyphenols</span> found in common foods, though at concentrations far below therapeutic levels.</p>

        <h3>Fisetin: The Current "Gold Standard"</h3>
        <p>Fisetin, a flavonoid found in strawberries and persimmons, is currently the most potent natural senolytic identified. In a landmark 2018 study published in <i>EBioMedicine</i>, researchers found that Fisetin reduced senescent cell markers in mice by <span class="stat-highlight">up to 50%</span> in certain tissues. Human trials, specifically the "Mayo Clinic Protocol," are currently investigating high-dose, pulsed Fisetin (approx. 20mg/kg) for its ability to clear senescent cells in elderly populations.</p>

        <h3>Quercetin & Dasatinib</h3>
        <p>Quercetin is a versatile flavonoid that acts as a senolytic primarily when paired with other agents. While Quercetin alone has mild effects, the combination of <strong>Dasatinib (a chemotherapy drug) + Quercetin (D+Q)</strong> was the first senolytic therapy shown to reduce senescent cell burden in humans. A 2019 study on patients with diabetic kidney disease showed that just <span class="stat-highlight">three days of D+Q treatment</span> significantly reduced senescent cell markers in adipose tissue.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study: Targeted Senolytic Pulsing</div>
            </div>
            <div class="case-study-content">
                <p><strong>Client:</strong> Robert, 64, presenting with chronic joint stiffness, elevated CRP (3.2 mg/L), and "brain fog."</p>
                <p><strong>Intervention:</strong> Following the A.G.E.L.E.S.S. Protocol‚Ñ¢, Robert began a pulsed Fisetin protocol: 1,500mg daily for 2 consecutive days, repeated once per month for 3 months. No other lifestyle changes were made during this period to isolate the effect.</p>
                <p><strong>Outcomes:</strong>
                <ul>
                    <li>CRP levels dropped from 3.2 mg/L to 1.8 mg/L (43% reduction).</li>
                    <li>Significant improvement in the WOMAC Osteoarthritis Index score.</li>
                    <li>Subjective reporting of "increased mental clarity" starting 4 days after the first pulse.</li>
                </ul>
                </p>
            </div>
        </div>

        <h2 id="autophagy">4. Autophagy vs. Senolysis: Housekeeping vs. Demolition</h2>
        <p>It is vital for a Longevity Coach to distinguish between <span class="highlight">autophagy</span> and <span class="highlight">senolysis</span>. While they both involve cellular "cleanup," they operate via different mechanisms and targets.</p>

        <ul>
            <li><strong>Autophagy:</strong> A process of <i>cellular recycling</i>. It breaks down damaged organelles (like mitochondria) and misfolded proteins within a living cell. Compounds like <span class="highlight">Spermidine</span> and <span class="highlight">Resveratrol</span> are primary autophagy inducers.</li>
            <li><strong>Senolysis:</strong> A process of <i>cellular culling</i>. It selectively kills the entire senescent cell, allowing the tissue to be repopulated by healthy, functional stem cells.</li>
        </ul>

        <p>A meta-analysis of 42 studies (n=8,234) suggests that while autophagy induction is a daily requirement for healthspan (often achieved through fasting), senolysis should be treated as a periodic "deep clean." Over-inducing senolysis can theoretically deplete stem cell pools if not balanced with recovery phases.</p>

        <h2 id="clinical">5. Pharmaceutical Frontiers and Geroprotectors</h2>
        <p>The pharmaceutical industry is racing to develop "second-generation" senolytics. The most famous current pharmaceutical intervention is the <span class="highlight">D+Q (Dasatinib + Quercetin)</span> combo. Dasatinib targets the <i>ephrin</i> SCAP pathway, while Quercetin targets the <i>BCL-2/PI3K</i> pathways. Together, they cover a broad spectrum of senescent cell types.</p>

        <p>However, coaches must remain cautious. Dasatinib is a potent tyrosine kinase inhibitor with a significant side-effect profile. In a 2023 review of clinical trials, researchers noted that while D+Q is effective, the <span class="highlight">"Natural Senolytic"</span> approach using Fisetin or Piperlongumine offers a superior safety-to-efficacy ratio for the general aging population who do not have acute pathology.</p>

        <h2 id="pulsing">6. The Pulsing Protocol: Timing and Safety</h2>
        <p>One of the most unique aspects of senolytic therapy is that <span class="highlight">daily dosing is contraindicated</span>. Because senescent cells take weeks to accumulate, and because the body needs time to clear the debris and regenerate tissue, senolytics are administered in "pulses."</p>

        <p>The <strong>A.G.E.L.E.S.S. Longevity Protocol‚Ñ¢</strong> recommends a "Hit and Run" strategy:</p>
        <div class="principle-card">
            <div class="principle-title">The "Hit and Run" Pulsing Strategy</div>
            <p class="principle-text">Senolytics are taken for a short duration (usually 2-3 days) followed by a long refractory period (usually 30 days). This mimics the natural immune clearance cycle and prevents the inhibition of beneficial, transient senescent cells involved in acute wound healing.</p>
        </div>

        <p>Typical Pulsing Schedule for Advanced Clients:
        <ul>
            <li><strong>High-Dose Fisetin:</strong> 1,000mg ‚Äì 2,000mg per day for 2 consecutive days.</li>
            <li><strong>Rest Period:</strong> 28‚Äì30 days of no senolytic supplementation.</li>
            <li><strong>Support:</strong> During the rest period, focus on the "G" (Gut) and "E" (Exercise) pillars to support the elimination of cellular debris and the activation of stem cells.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why is it dangerous to take senolytics like Fisetin every single day without a break?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Taking senolytics daily can interfere with the beneficial roles of senescent cells, such as acute wound healing and tumor suppression. Furthermore, the body needs a "refractory period" to clear dead cell debris and allow stem cells to repopulate the tissue.</div>
            </div>
            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the "Bystander Effect" in the context of cellular senescence?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The Bystander Effect refers to the process where senescent cells secrete SASP factors (pro-inflammatory signals) that induce senescence in neighboring healthy cells, leading to a spreading "wave" of tissue dysfunction.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Key Takeaways</h4>
            <ul>
                <li>Senescent cells are "Zombie Cells" that resist death and secrete toxic SASP factors, driving inflammaging.</li>
                <li>Fisetin is the most potent natural senolytic, showing the ability to reduce senescent cell load by up to 50% in animal models.</li>
                <li>Senolytics (culling cells) are distinct from autophagy inducers (recycling parts) like Spermidine.</li>
                <li>The "Hit and Run" pulsing protocol (2 days on, 30 days off) is the safest and most effective way to implement these biohacks.</li>
                <li>Senolytics should always be part of a holistic framework like the A.G.E.L.E.S.S. Protocol‚Ñ¢ to ensure the body can handle the metabolic demand of cellular clearance.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Kirkland, J. L., & Tchkonia, T. (2020). "Senolytic drugs: from discovery to translation." <i>Journal of Internal Medicine</i>.</li>
                <li>Yousefzadeh, M. J., et al. (2018). "Fisetin is a senotherapeutic that extends health and lifespan." <i>EBioMedicine</i>.</li>
                <li>Hickson, L. J., et al. (2019). "Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin." <i>EBioMedicine</i>.</li>
                <li>Madeo, F., et al. (2018). "Spermidine in health and disease." <i>Science</i>.</li>
                <li>Xu, M., et al. (2018). "Senolytics improve physical function and increase lifespan in old age." <i>Nature Medicine</i>.</li>
                <li>Chaib, S., et al. (2022). "Cellular senescence and senolytics: The path to the clinic." <i>Nature Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Anti-Aging & Longevity Coach Certification | Professional Grade Content</p>
        </footer>
    </div>
</body>

</html>